Role of interleukin 4 in Spanish multiple sclerosis patients

被引:20
|
作者
Urcelay, E
Santiago, JL
Mas, A
Martínez, A
de las Heras, V
Arroyo, R
de la Concha, EG
机构
[1] Hosp Univ San Carlos, Dept Immunol, Madrid 28040, Spain
[2] Hosp Univ San Carlos, Dept Neurol, Madrid, Spain
关键词
interleukin; 4; multiple sclerosis; susceptibility;
D O I
10.1016/j.jneuroim.2005.07.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 4 is a Th2 cytokine with potent anti-inflammatory properties. Protection from autoimmune encephalomyelitis and multiple sclerosis has been achieved with IL-4 therapy and IL-4 deficient mice developed a more severe form of clinical disease. Four polymorphisms within the IL-4 gene are in strong linkage disequilibrium, including one in the promoter at 590, which controls transcriptional activity. An MS protective role for the heterozygous genotype was confirmed in Spain (exon-1 + 33 C/T: p=0.003, OR [CI]=0.57 [0.38-0.84]), probably indicative of an MS protection haplotype at 5q31 locus, No difference among MS clinical forms or age at onset was detected. (C) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 50 条
  • [41] Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis
    Libbey, Jane E.
    Tsunoda, Ikuo
    Fujinami, Robert S.
    JOURNAL OF NEUROVIROLOGY, 2012, 18 (06) : 471 - 478
  • [42] A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease
    Goertsches, R
    Villoslada, P
    Comabella, M
    Montalban, X
    Navarro, A
    de la Concha, EG
    Arroyo, R
    de Munain, AL
    Otaegui, D
    Palacios, R
    Perez-Tur, J
    Jonasdottir, A
    Benediktsson, K
    Fossdal, R
    Sawcer, S
    Setakis, E
    Compston, A
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 143 (1-2) : 124 - 128
  • [43] Multiple sclerosis associates with LILRA3 deletion in Spanish patients
    D Ordóñez
    A J Sánchez
    J E Martínez-Rodríguez
    E Cisneros
    E Ramil
    N Romo
    M Moraru
    E Munteis
    M López-Botet
    J Roquer
    A García-Merino
    C Vilches
    Genes & Immunity, 2009, 10 : 579 - 585
  • [44] Multiple sclerosis associates with LILRA3 deletion in Spanish patients
    Ordonez, D.
    Sanchez, A. J.
    Martinez-Rodriguez, J. E.
    Cisneros, E.
    Ramil, E.
    Romo, N.
    Moraru, M.
    Munteis, E.
    Lopez-Botet, M.
    Roquer, J.
    Garcia-Merino, A.
    Vilches, C.
    GENES AND IMMUNITY, 2009, 10 (06) : 579 - 585
  • [45] Validation of the Spanish version of the Treatment Burden Questionnaire in multiple sclerosis patients
    Fiol, M. P.
    Ysrraelit, M. C.
    Vanotti, S.
    Vasquez, F.
    Terrasa, S.
    Correale, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 799 - 800
  • [46] Factors related to medicinal use of cannabis in Spanish patients with multiple sclerosis
    Martinez-Rodriguez, I. E.
    Saiz, A.
    Munteis, E.
    Blanco, Y.
    Abanades, S.
    Roquer, J.
    MULTIPLE SCLEROSIS, 2007, 13 : S267 - S267
  • [47] Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis
    Oreja-Guevara, Celia
    Rio, Jordi
    Gobartt, Ana L.
    REVISTA DE NEUROLOGIA, 2015, 61 (04) : 145 - 152
  • [48] Interleukin genes polymorphisms in Multiple Sclerosis
    Leon, V. J.
    Caho, J. L.
    Perez, R. Rodriguez
    Sevillano, M. D.
    Gamazo, S.
    Bowakin, D.
    TISSUE ANTIGENS, 2006, 67 (06): : 550 - 550
  • [49] Interferon γ and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment
    Franciotta, D
    Zardini, E
    Bergamaschi, R
    Andreoni, L
    Cosi, V
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (01): : 123 - 126
  • [50] Assessment of the role of telemedicine in the outcome of multiple sclerosis patients
    Ahmed, Mohamed Abd El-khalik
    Zakaria, Magd Fouad
    Abd Elaziz, Azza Abd Elnasser
    Fouad, Mohamed Mahmoud
    Elbokl, Ahmed Mohamed
    Swelam, Mahmoud Saad
    EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2023, 59 (01):